PMID- 12149226 OWN - NLM STAT- MEDLINE DCOM- 20020912 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 100 IP - 4 DP - 2002 Aug 15 TI - Genomic abnormalities in monoclonal gammopathy of undetermined significance. PG - 1417-24 AB - Translocations involving immunoglobulin (Ig) loci and chromosome 13 monosomy (Delta 13) are frequent cytogenetic findings in multiple myeloma (MM). Similar chromosomal aberrations have been identified in the monoclonal gammopathy of undetermined significance (MGUS), but their prevalence and significance remain uncertain. Bone marrow from 72 patients with MGUS (n = 62) and smoldering MM (n = 10) was evaluated for translocations between the Ig heavy chain (IgH) and chromosomes 4, 11, and 16, translocations involving Ig light chain-lambda (IgL-lambda, and Delta 13. Fluorescence in situ hybridization (FISH) analysis was done on clonal plasma cells (PCs) detected by immunofluorescence (cIg-FISH) of the cytoplasmic light chain. We also studied cells for cyclin D1 and FGFR3 up-regulation by immunohistochemistry and immunofluorescence, respectively. Twenty-seven (46%) of 59 patients had IgH translocations, and 4 (11%) of 37 had an IgL-lambda translocation. A t(11;14)(q13;q32) was found in 15 (25%) of 59 patients, a t(4;14)(p16.3;q32) in 9% of patients, and a t(14;16)(q32;q23) in 5% of patients. All patients with t(4;14)(p16.3;q32) tested (n = 3) had intense cytoplasmic fluorescence with an anti-FGFR3 antibody. PC nuclear staining of cyclin D1 was only observed in patients with t(11;14)(q13;q32); Delta 13 was detected in the clonal PCs in 50% of patients. The percentage of abnormal PCs varied with any given abnormality. No obvious clinical or biologic correlations were associated with these chromosome abnormalities. Similar translocations are found in both MGUS and MM, including t(4;14)(p16.3;q32) and t(14;16)(q32;q23). Moreover, Delta 13 is common in MGUS and unlikely to play a predominant role in the evolution of MGUS to MM. FAU - Fonseca, Rafael AU - Fonseca R AD - Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA. fonesca.rafael@mayo.edu FAU - Bailey, Richard J AU - Bailey RJ FAU - Ahmann, Gregory J AU - Ahmann GJ FAU - Rajkumar, S Vincent AU - Rajkumar SV FAU - Hoyer, James D AU - Hoyer JD FAU - Lust, John A AU - Lust JA FAU - Kyle, Robert A AU - Kyle RA FAU - Gertz, Morie A AU - Gertz MA FAU - Greipp, Philip R AU - Greipp PR FAU - Dewald, Gordon W AU - Dewald GW LA - eng GR - P01 CA62242/CA/NCI NIH HHS/United States GR - R01 CA83724-01/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Immunoglobulin Heavy Chains) RN - 0 (Immunoglobulin Light Chains) RN - 0 (Receptors, Fibroblast Growth Factor) RN - 136601-57-5 (Cyclin D1) RN - EC 2.7.10.1 (FGFR3 protein, human) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Receptor, Fibroblast Growth Factor, Type 3) SB - IM CIN - Blood. 2003 Feb 15;101(4):1653. PMID: 12560243 MH - Aneuploidy MH - *Chromosome Aberrations MH - Chromosomes, Human, Pair 11 MH - Chromosomes, Human, Pair 13 MH - Chromosomes, Human, Pair 14 MH - Chromosomes, Human, Pair 16 MH - Chromosomes, Human, Pair 4 MH - Cyclin D1/analysis MH - Fluorescent Antibody Technique MH - Humans MH - Immunoglobulin Heavy Chains/genetics MH - Immunoglobulin Light Chains/genetics MH - Immunohistochemistry MH - In Situ Hybridization, Fluorescence MH - Multiple Myeloma/genetics MH - Paraproteinemias/*genetics MH - Prognosis MH - *Protein-Tyrosine Kinases MH - Receptor, Fibroblast Growth Factor, Type 3 MH - Receptors, Fibroblast Growth Factor/analysis MH - Translocation, Genetic EDAT- 2002/08/01 10:00 MHDA- 2002/09/13 10:01 CRDT- 2002/08/01 10:00 PHST- 2002/08/01 10:00 [pubmed] PHST- 2002/09/13 10:01 [medline] PHST- 2002/08/01 10:00 [entrez] AID - S0006-4971(20)59337-3 [pii] PST - ppublish SO - Blood. 2002 Aug 15;100(4):1417-24.